Konstantinos Kelaidonis

Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2

Harry Ridgway, Graham J. Moore, Thomas Mavromoustakos et al. · Computational and Structural Biotechnology Journal · 2022 · 40 citations · Full text

Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy

Harry Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis et al. · Viruses · 2022 · 36 citations · Full text

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity

Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis et al. · Viruses · 2023 · 25 citations · Full text

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19

Graham J. Moore, José Maria Pires, Konstantinos Kelaidonis et al. · Biomolecules · 2021 · 23 citations · Full text

Medicinal Chemistry, Receptor Interactions, Signal Transduction +15

An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies

George Agelis, Panagiota Roumelioti, Amalia Resvani et al. · Journal of Computer-Aided Molecular Design · 2010 · 21 citations

Medicinal Chemistry, Biochemistry, Medicine +9